Anatomical Therapeutic Chemical • C08CA13 • lercanidipine

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

C01 Cardiac therapy

C02 Antihypertensives

C03 Diuretics

C04 Peripheral vasodilators

C05 Vasoprotectives

C07 Beta blocking agents

C08 Calcium channel blockers

C08C Selective calcium channel blockers with mainly vascular effects

C08CA Dihydropyridine derivatives

C08CA01 amlodipine Indicated for: hypertension

C08CA02 felodipine Indicated for: hypertension

C08CA04 nicardipine Indicated for: hypertension

C08CA05 nifedipine Indicated for: hypertension; angina pectoris

C08CA06 nimodipine Indicated for: hypertension

C08CA07 nisoldipine Indicated for: hypertension

C08CA08 nitrendipine Indicated for: hypertension

C08CA09 lacidipine Indicated for: hypertension

C08CA13 lercanidipine Indicated for: hypertension

C08CX Other selective calcium channel blockers with mainly vascular effects

C08D Selective calcium channel blockers with direct cardiac effects

C08E Non-selective calcium channel blockers

C08G Calcium channel blockers and diuretics

C09 Agents acting on the renin-angiotensin system

C10 Lipid modifying agents

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various